John Mazarakis & Vireo Growth Inc.

John Mazarakis: John Mazarakis, CEO of Vireo Growth Inc., developed the partnership and will serve on the board of managers of Vireo Health of New York, LLC, ensuring continued operational support and regulatory compliance.

Vireo Growth Inc.: Vireo Growth Inc. entered into a strategic partnership with Ace Venture of NY, LLC, transferring 51% ownership of its subsidiary Vireo Health of New York, LLC to Ace Venture of NY, LLC. This partnership aims to align with New York's social equity framework in the cannabis industry.

John Mazarakis: John Mazarakis, CEO of Vireo Growth Inc., expressed enthusiasm for the acquisition of Eaze, highlighting its strategic importance for market expansion and enhanced delivery capabilities.

Vireo Growth Inc.: Vireo Growth Inc. closed its acquisition of Eaze, expanding its operating footprint to 10 states and increasing its retail presence and cultivation capacity. This acquisition is expected to enhance Vireo Growth Inc.'s IP portfolio and market position.

John Mazarakis: John Mazarakis, CEO of Vireo Growth Inc., commented on the company's Q1 performance, emphasizing integration, optimization, and opportunistic acquisition-related growth.

Vireo Growth Inc.: Vireo Growth Inc. reported strong Q1 2026 financial results with significant revenue growth driven by recent acquisitions, positioning itself as the 4th largest cannabis company by pro forma revenue. The company also announced further acquisitions and a joint venture, indicating continued expansion.

John Mazarakis: John Mazarakis, CEO of Vireo Growth Inc., commented on the acquisition, highlighting its benefits for Vireo Growth Inc.'s balance sheet and supply chain management.

Vireo Growth Inc.: Vireo Growth Inc. completed the acquisition of Scotts Miracle-Gro Company — Hawthorne Gardening Company LLC, strengthening its balance sheet with approximately US$110 million in cash and net working capital and expanding its procurement platform.